Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Emerging Infectious Diseases|October 11, 2022
Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and ThailandYifan Li, Mélanie Merbah, Suzanne Wollen-Roberts, et al.
Ebiomedicine|April 22, 2020
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infectionAdam T Waickman, Gregory D Gromowski, Wiriya Rutvisuttinunt, et al.
Plos Pathogens|August 4, 2017
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaquesMichael K McCracken, Gregory D Gromowski, Heather L Friberg, et al.
NPJ Vaccines|March 19, 2023
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodiesShikha Shrivastava, Joshua M Carmen, Zhongyan Lu, et al.
Mbio|August 29, 2025
First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challengeVincent Dussupt, Jaime L Jensen, Paul V Thomas, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohortsPhilip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
Nature Communications|May 29, 2025
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohortsPhilip K Ehrenberg, Aviva Geretz, Meta Volcic, et al.
AIDS Research and Human Retroviruses|October 6, 2012
The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120Nicos Karasavvas, Erik Billings, Mangala Rao, et al.
Science Advances|November 23, 2022
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFNJingyou Yu, Paul V Thomas, Katherine McMahan, et al.
Structure (London, England : 1993)|December 29, 2023
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domainRajeshwer S Sankhala, Vincent Dussupt, Wei-Hung Chen, et al.
Pageof 11